Company intelligence / Profile preview

Tiger Wound Care

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Tiger Wound Care is an early-stage biotechnology company focused on developing advanced wound care solutions for chronic and non-healing wounds. The company's primary technology involves a proprietary delivery system designed to provide sustained release of therapeutic agents directly to the wound bed. Their lead programs target common complications such as diabetic foot ulcers and venous leg ulcers by combining physical protection with antimicrobial and regenerative properties. Tiger Wound Care aims to improve patient outcomes and reduce the economic burden of chronic wound management through its innovative hydrogel-based platforms.

Therapeutic areas: CardiovascularEndocrinologyDermatologyInfectious Diseases
Modalities: DeviceHydrogel-based drug delivery therapySmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Tiger Wound Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tiger Wound Care.

Explore the full profile